Wang Guangyi, Zhang Laiguo, Wu Xiaomin, Das Debasis, Ruhrmund Donald, Hooi Lisa, Misialek Shawn, Ravi Rajagopalan P T, Buckman Brad O, Kossen Karl, Seiwert Scott D, Beigelman Leonid
Discovery Research, InterMune, Inc., Brisbane, CA 94005, USA.
Bioorg Med Chem Lett. 2009 Aug 1;19(15):4484-7. doi: 10.1016/j.bmcl.2009.05.021. Epub 2009 May 9.
3-(1,1-Dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives as potential anti-HCV drugs targeting NS5B polymerase have been investigated. Their synthesis, HCV NS5B polymerase inhibition, and replicon activity are discussed.